Related Experiment Videos
[Renal function during treatment with angiotensin converting enzyme inhibitors]
K Rasmussen1, M Heitmann, J I Nielsen
1Medicinsk afdeling, Amtssygehuset Roskilde.
Ugeskrift for Laeger
|September 25, 1995
Summary
Angiotensin-converting enzyme (ACE) inhibitors can benefit kidney function in diabetic nephropathy and slow decline in other kidney diseases. However, regular monitoring of kidney function is crucial, especially in patients with atherosclerosis.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Context:
- Increasing use of ACE inhibitors for hypertension and heart failure, particularly in elderly patients with atherosclerosis.
- ACE inhibitors impact renal hemodynamics and kidney function, necessitating careful patient monitoring.
- Review focuses on the dual effects of ACE inhibitors on renal function.
Purpose:
- To review the effects of ACE inhibitors on renal hemodynamics and kidney function.
- To highlight the benefits and risks associated with ACE inhibitor use in various kidney conditions.
- To provide guidance on monitoring kidney function during ACE inhibitor therapy.
Summary:
- ACE inhibitors show positive effects in preserving kidney function in diabetic nephropathy and reducing proteinuria in other kidney diseases.
- Negative impacts can occur, particularly in patients with atherosclerotic stenosis of renal arteries.
- ACE inhibitors are considered the preferred treatment for hypertension in diabetic nephropathy.
Impact:
- ACE inhibitors may preserve kidney function and reduce disease progression in specific nephropathies.
- Careful monitoring of renal function is essential, especially in patients with comorbidities like atherosclerosis.
- Establishes ACE inhibitors as a key therapeutic option for managing hypertension and kidney disease.